Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Germline Testing in Patients with Breast Cancer

Publication Date: January 3, 2024

Last Updated: January 4, 2024

Treatment

Recommendation 1.1

All patients newly diagnosed with breast cancer with stage I–III or de novo stage IV/metastatic disease who are 65 years of age or younger at diagnosis should be offered BRCA1/2 testing. (CB, , , )

Germline Testing in Patients with Breast Cancer

Treatment

Recommendation 1.1

Overview

Title

Authoring Organizations